Predictors and management of relapse to Axicabtagene Ciloleucel in patients with aggressive B-cell lymphoma

Autor: Forero-Forero, Jose Vicente, Lengerke-Diaz, Paula A., Moreno-Cortes, Eider, Melody, Megan, Rahman, Zaid Abdel, Rosenthal, Allison C., Kharfan-Dabaja, Mohamed A., Castro, Januario E.
Zdroj: In Hematology/Oncology and Stem Cell Therapy September 2021
Databáze: ScienceDirect